Aerovate Therapeutics
Stock Forecast, Prediction & Price Target

Aerovate Therapeutics Financial Estimates

Aerovate Therapeutics Revenue Estimates

Aerovate Therapeutics EBITDA Estimates

Aerovate Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $8.14M
Low: $8.14M
High: $8.14M
avg. 0%
Avg: $16.49M
Low: $16.49M
High: $16.49M
avg. 102.47%
Avg: $75.61M
Low: $75.61M
High: $75.61M
avg. 358.40%
Net Income
 
% change YoY
$-22.96M
 
N/A
$-51.51M
 
-124.32%
$-75.52M
 
-46.61%
Avg: $-54.05M
Low: $-89.00M
High: $-4.21M
avg. 28.43%
Avg: $-17.24M
Low: $-21.06M
High: $-6.84M
avg. 68.08%
Avg: $-33.09M
Low: $-33.09M
High: $-33.09M
avg. -91.86%
Avg: $-27.10M
Low: $-27.10M
High: $-27.10M
avg. 18.10%
EBITDA
 
% change YoY
$-23.00M
 
N/A
$-53.16M
 
-131.09%
$-81.31M
 
-52.93%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.94
 
N/A
-$2.1
 
-123.40%
-$2.87
 
-36.66%
Avg: -$1.51
Low: -$3.38
High: -$0.16
avg. 47.38%
Avg: -$0.55
Low: -$0.8
High: -$0.26
avg. 63.41%
Avg: -$1.26
Low: -$1.26
High: -$1.26
avg. -127.47%
Avg: -$1.03
Low: -$1.03
High: -$1.03
avg. 18.10%
Operating Expenses
 
% change YoY
$23.02M
 
N/A
$53.23M
 
131.24%
$81.40M
 
52.91%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Aerovate Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 5.68% in 2025-2028.

We have gathered data from 5 analysts. Their low estimate is -89.00M, average is -54.05M and high is -4.21M.

What is Aerovate Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 115.21% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Aerovate Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 0.35% in 2025-2028.

We have gathered data from 5 analysts. Their low earnings per share estimate is -$3.38, average is -$1.51 and high is $-0.16.

What is the best performing analyst?

In the last twelve months analysts have been covering Aerovate Therapeutics stock. The most successful analyst is Eun Yang.